LAGUNA BEACH, Calif.--(BUSINESS WIRE)--Cobalis Corp. (Pink Sheets: CLSC), a pharmaceutical biotech company specializing in the development of anti-allergy medications, announced today that they have entered into a Master Broker agreement with Melodic Distribution Company (MDC). The goal of the agreement is to take advantage of MDC’s strong international distribution channels and strategic partners.
